Showing results (961-970 of 2,556) with videos related to
Sort By:
Pageof 256
Therapeutics and Clinical Risk Management|March 2, 2016
New combinations in the treatment of COPD: rationale for aclidinium-formoterolCristoforo Incorvaia, Marcello Montagni, Elena Makri, et al.Therapeutics and Clinical Risk Management|March 2, 2016
Influence of MDR1 methylation on the curative effect of interventional embolism chemotherapy for cervical cancerZhi Huang, Shuai Zhang, Yaping Shen, et al.Therapeutics and Clinical Risk Management|March 2, 2016
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerationsIlya Ayzenberg, Robert Hoepner, Ingo KleiterTherapeutics and Clinical Risk Management|March 4, 2016
Bacterial profile of urinary tract infection and antimicrobial susceptibility pattern among pregnant women attending at Antenatal Clinic in Dil Chora Referral Hospital, Dire Dawa, Eastern EthiopiaBehailu Derese, Haji Kedir, Zelalem Teklemariam, et al.Therapeutics and Clinical Risk Management|December 10, 2015
The limits of oral therapy in pulmonary arterial hypertension managementQian-Qian Liu, Zhi-Cheng JingTherapeutics and Clinical Risk Management|November 16, 2013
Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumabHugh J FreemanTherapeutics and Clinical Risk Management|November 21, 2013
Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot studyLuigi Rossi, Federica Tomao, Giuseppe Lo Russo, et al.Therapeutics and Clinical Risk Management|September 5, 2014
Emerging treatments in type 2 diabetes: focus on canagliflozinMarek Rosiak, Susanna Grzeszczak, Dariusz A Kosior, et al.Therapeutics and Clinical Risk Management|December 20, 2013
Treatment of bisphosphonate related osteonecrosis following root canal therapy at the 1-year follow-up: report of two casesFigen Kaptan, Meric Karapinar Kazandag, Ufuk IseriTherapeutics and Clinical Risk Management|December 8, 2015
Long-term safety and efficacy of infliximab for the treatment of ankylosing spondylitisOfir Elalouf, Ori ElkayamPageof 256